George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...

Roche Holding AG is willing to pay more than $1 billion to solve one of the biggest challenges of gene therapy: delivery.The ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...

Roche will use Dyno’s technology, through which Dyno applies AI and high-throughput in vivo data collection to engineering AAV capsids.

Roche has inked a new deal with Dyno Therapeutics to develop next-generation AAV capsids for gene therapies targeting ...

US artificial intelligence (AI) to gene therapy focussed biotech Dyno Therapeutics today announced its second research ...

Existing gene therapies have primarily used a small number of naturally occurring AAV vectors limited by low delivery efficiency as well as problems with pre-existing immunity and manufacturability.

On today's episode of Car Trek, AutoTempest challenged the guys to test their used exotic cars' power levels in a dyno test.

Explosives and blasting company Dyno Nobel has been going for 180 years, but it now has its sights set on the future of the sector. Braden Lusk, chief ...

But a session of E-tuning and another on an actual dyno was hugely beneficial to my humble Civic. Now, I’d tell anyone interested in hot rodding their car at all to look into computer tuning ...

Dyno Nobel, a global leader in commercial explosives, continues to expand its electronic detonator line with their new ...